leuprorelin acetate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
BI ELIGARD CP (Eligard 1 month 7.5mg and MPL-Bicalutamide 50mg, 28 pack) AUST R: 237653Active ingredients:
leuprorelin acetate
bicalutamide
Dosage form:
Injection, modified release
Sponsor:
Mundipharma Pty Ltd
Phone:
1800 188 009
|
Deletion from market:
14 Aug 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative presentation is available.
|
BI ELIGARD CP (Eligard 3 month 22.5mg and MPL-Bicalutamide 50mg, 28 pack) AUST R: 238311Active ingredients:
leuprorelin acetate
bicalutamide
Dosage form:
Injection, modified release
Sponsor:
Mundipharma Pty Ltd
Phone:
1800 188 009
|
Deletion from market:
14 Aug 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative presentation is available
|
BI ELIGARD CP (Eligard 3 month 22.5mg and MPL-Bicalutamide 50mg, 84 pack) AUST R: 237652Active ingredients:
leuprorelin acetate
bicalutamide
Dosage form:
Injection, modified release
Sponsor:
Mundipharma Pty Ltd
Phone:
1800 188 009
|
Deletion from market:
14 Aug 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative presentation is available
|